Traws Pharma (TRAW) Receivables (2014 - 2026)
Traws Pharma (TRAW) posted quarterly Receivables of $1.7 million for Q1 2026, up 2.0% year-over-year from $1.7 million in Q1 2025, and down 55.54% quarter-over-quarter from $3.8 million in Q4 2025.
Traws Pharma (TRAW) Receivables (2014 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Receivables for 13 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables rose 2.0% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 2.0% YoY), while the FY2025 annual figure was $3.8 million, up 114.96% from the prior year.
- Receivables slipped to $1.7 million in Q1 2026 per TRAW's latest filing, from $3.8 million in the prior quarter.
- Across five years, Receivables topped out at $3.8 million in Q4 2025 and bottomed at $17000.0 in Q1 2023.
- Historically, Receivables has averaged $856058.8 across 5 years, with a median of $28000.0 in 2022.
- Annual changes were most pronounced in 2023 — Receivables sank 39.29% — and 2024, when it soared 11683.33%.
- Traws Pharma's Receivables stood at $29000.0 in 2022, then tumbled by 37.93% to $18000.0 in 2023, then soared by 9705.56% to $1.8 million in 2024, then jumped by 114.96% to $3.8 million in 2025, then tumbled by 55.54% to $1.7 million in 2026.
- Business Quant data shows TRAW's Receivables at $1.7 million in Q1 2026, $3.8 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 912.74 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 215.33 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.09 Bn |
| 10 | Traws Pharma | 5.60 Mn | 588,417.40 | - | 3.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | 3.79 Mn |
| Sep 30, 2025 | 1.99 Mn |
| Jun 30, 2025 | 1.32 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 1.77 Mn |
| Sep 30, 2024 | 2.12 Mn |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Sep 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Mar 31, 2023 | 17,000.00 |
| Dec 31, 2022 | 29,000.00 |
| Sep 30, 2022 | 28,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | 27,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Sep 30, 2021 | 29,000.00 |
| Jun 30, 2021 | 27,000.00 |